DUBLIN, June 29, 2022 /PRNewswire/ — The report “Digital Biomanufacturing Market – A Global and Regional Analysis: Analysis and Forecast, 2022-2031” has been added to from ResearchAndMarkets.com offer.
The global digital biomanufacturing market report highlights that the market has been valued at $15,768.9 million in 2021 and is expected to reach $55,564.9 million by the end of 2031.
Market Report Coverage – Digital Biofabrication
- By technology type – Process analytics technologies, data analytics software, AI and IoMT solutions, predictive analytics and digital twin technologies and others
- By end user – Biopharmaceutical companies and academic and research institutes
- By Application – Bioprocess Optimization and Process Analysis, Biomanufacturing Process Automation and Control, and Flexible Manufacturing
- By region – North America, Europe, Asia Pacific and Rest of the World
Market Growth Factors
- Automation process on the rise in various industries
- Increased focus on process efficiency and flexibility in manufacturing
- Transition to digitalization and biomanufacturing in healthcare
- Lack of technology adoption and awareness resulting in low return on investment
- Lack of data security in bioproduction parameters
- Increased demand for organic products
Industry Overview of the Digital Biomanufacturing Market
The global digital biomanufacturing market is a huge market comprised of various software and platforms that include process analytics technologies, data analytics software, AI and IoMT solutions, predictive analytics, and digital twin, etc. If application is involved, we have bioprocess optimization and process analysis, biomanufacturing process automation and control, and flexible manufacturing.
The Global Digital Biomanufacturing Market report highlights that the market was valued at $15,768.9 million in 2021 and is expected to reach $55,564.9 million by the end of 2031. The market is expected to grow at a CAGR of 13.12% during the forecast period from 2022 to 2031.
Global Digital Biomanufacturing Market Drivers
Smart factories have the potential to improve sustainability by enabling real-time production monitoring, with automated control systems reducing the number of failed batches and maintenance costs. Thus, the ability of biomanufacturing companies to autonomously and appropriately control bioprocesses to their optimum state is essential, as this helps to reduce or maintain production costs and increase yields while maintaining quality consistency. some products. This will help energize the market.
In today’s biomanufacturing companies, digitalization in the form of Big Data-inspired applications and the digital twin are hot topics. As a result, many companies allocate personnel and equipment to these applications. In order to assess the existing situation and projected future difficulties in integrating digitalization principles into biotech production processes, a targeted survey was carried out among individuals from the Danish biotech industry.
Global Digital Biomanufacturing Market Challenges
Factors restraining the growth of the digital biomanufacturing market include lack of technology adoption and awareness leading to low return on investment. ROI calculations allow a company to establish and use project evaluation metrics that can be used consistently across a portfolio and go beyond simple business cases.
Many stakeholders, including industry, governments, and healthcare providers, need to pay attention to cybersecurity in order to deliver safe and effective biopharmaceuticals. The cybersecurity breach could have a direct impact on patients, ranging from compromised data privacy to production disruptions jeopardizing the global response to the pandemic. In today’s economy, where advanced manufacturing technologies and digital strategies are becoming the norm, maintaining cybersecurity is a top concern.
Global Digital Biomanufacturing Market Opportunities
The growth opportunity of the global digital biomanufacturing market lies in the opportunity of increased demand for biologics. It is desirable to develop an alternative manufacturing technique that relies less on human labor and the transition steps between unit activities require a smaller plant footprint and is more open to scalability, automation and adaptation. through various drug modalities.
Impact of COVID-19 on the Global Digital Biomanufacturing Market
The COVID-19 pandemic had propelled the global digital biomanufacturing market. The impact of the global pandemic digital biomanufacturing market has had a positive impact on the market. One of the major impacts of COVID-19 on global digital biomanufacturing has been to understand the importance of automation and innovation of new technologies.
Global Digital Biomanufacturing Market (by Technology)
The global digital biomanufacturing market has been segmented on the basis of technology type into eight different segments, namely process analytics technologies, data analytics software, AI and IoMT solutions, l predictive analytics and digital twin technologies, and others.
Main topics covered:
1.1 Market Outlook
1.2 Industry Outlook
1.2.3 Patent analysis
1.3 Impact of COVID-19
1.4 Commercial dynamics
2 Global Digital Biomanufacturing Market by Application
2.1 Opportunity assessment
2.2 Growth share matrix
2.3 Automation and control of biomanufacturing processes
2.4 Bioprocess optimization and process analysis
2.5 Flexible Manufacturing
3 Global Digital Biomanufacturing Market by End User
3.1 Opportunity assessment
3.2 Growth share matrix
3.3 Biopharmaceutical companies
3.4 Academic and research institutes
4 Global Digital Biomanufacturing Market by Technology
4.1 Opportunity assessment
4.2 Growth share matrix
4.3 AI and IoMT solutions
4.4 Process analysis technologies
4.5 Data analysis software
4.6 Predictive analytics and digital twin technologies
- Atos SE
- Agilent Technologies Inc.
- Danaher Company
- Donaldson Company, Inc.
- Emerson Electric Co.
- General electricity company
- Honeywell International Inc.
- SAP SE
- Siemens Healthineers SA
- Bota Biosciences
- Culture Biosciences
- e-matica srl
- Exponential Genomics, Inc.
- OVO Biomanufacturing
- Symphony Innovation, LLC
For more information about this report visit https://www.researchandmarkets.com/r/xsdac
Research and Markets
For EST office hours, call +1-917-300-0470
For USA/CAN call toll free +1-800-526-8630
For GMT office hours call +353-1-416-8900
US Fax: 646-607-1904
Fax (outside the US): +353-1-481-1716
SOURCE Research and Markets